2 Bridge joins BioWin
We are happy to announce that 2 Bridge has recently become member of BioWin.
September – New Hires
We are very pleased to announce that 2 Bridge has welcomed Kevin Hollevoet as new team member.
2 Bridge Team Day
In the light of our growing company and our strong belief in teamwork, we have had our first 2 Bridge Team Day at the beginning of June.
2 Bridge and Inovigate at Knowledge for Growth
Similar to the past 2 years, 2 Bridge was again present as exhibitor at the 14th edition of Knowledge for Growth, which took place at May 17th, 2018.
2 Bridge is attending BioEquity and Knowledge for Growth
We are pleased to announce that 2 Bridge will be present at the next edition of Bio€quity and Knowledge for Growth, organized in Ghent, from May 14th – May 17th, 2018. We are very much looking forward to meeting you this week.
2 Bridge receives French Research Tax Credit accreditation (CIR)
We are pleased to inform you that the French Ministry of Higher Education, Research and Innovation has granted our company the French Research Tax Credit accreditation.
Microbiome – White Paper
Changes in the gut microbiome are associated with numerous diseases. Research shows – convincingly – that microbiome modulation may lead to a cure. Why is it then, that the efforts to treat patients by targeting the gut microbiome fail?
2 Bridge on the 2018 Belgian State Visit to Canada
We proudly announce that Ann Meulemans, CEO & Managing Partner of 2 Bridge, is taking part in the Belgian State Visit to Canada.
January New Hires
2 Bridge keeps on growing.
We are pleased to have welcomed three new team members in January, 2018.
How can you minimize the impact that Drug Transporters have on your project?
In just 3 pages you will learn which aspects to consider when progressing your small molecule project through Development.